Browsing by Author "Glumac, S. (33467624700)"
Now showing 1 - 3 of 3
- Results Per Page
 - Sort Options
 
- Some of the metrics are blocked by yourconsent settings
Publication Expression of matrix metalloproteinases and endogenous inhibitors in abdominal aortic aneurysm and aortoiliac occlusive disease (syndrome leriche)(2017) ;Vasic, N. (57201797483) ;Glumac, S. (33467624700) ;Pejic, S. (6602841944) ;Amidzic, L.J. (57224488902) ;Tadic Latinovic, L.J. (57201801229) ;Dozic, B. (6507142704) ;Hinic, S. (55208518100)Maksimovic, Z. (26537806600)Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play a complex role in the pathogenesis of atherosclerosis. We compared (1) the histopathological findings in patients with abdominal aortic aneurysms (AAA) and aortoiliac occlusive disease (AOD); (2) the expression of MMP-2/MMP-9 and TIMP-1/TIMP-2 in aortic layers, inflammatory cells and smooth muscle cells (SMCs), aiming to identify the common underlying pathogenic mechanisms of the disease development. Samples were obtained from 30 patients with AAA and 30 with AOD. Aortic histology and immunohistochemistry were performed to evaluate inflammatory changes and MMP and TIMP expression. Thrombosis and ulceration were more frequent in AOD than in AAA. The MMP-9 expression was elevated in all aortic layers of AAA patients and in media/adventitia of AOD patients, mainly followed by lower expression of its inhibitor TIMP-1. Higher MMP-9 expression was also found in SMCs and macrophages of both AAA and AOD specimens, while higher TIMP-1/TIMP-2 were predominantly observed in the lymphocytes and macrophages of the aneurysm. These results showed that both conditions exhibited increased MMP-9 expression; however, the MMP expression pattern differed to some degree between the aneurysms and occlusive disease. The variations in molecular mechanisms underlying dilatative/stenosing disease warrant further investigation. © 2017 Charles University. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Heart rate dynamics in doxorubicin-induced cardiomyopathy(2015) ;Lončar-Turukalo, T. (24478354200) ;Vasić, M. (56277862600) ;Tasić, T. (56394333000) ;Mijatović, G. (55513889700) ;Glumac, S. (33467624700) ;Bajić, D. (56186463400)Japunžić-Žigon, N. (56572866800)The clinical use of doxorubicin, an effective chemotherapeutic is hampered by the development of irreversible cardiotoxicity. Here we test time-frequency analysis of heart rate (HR) variability (HRV) for early detection of doxorubicin-induced cardiotoxicity. Experiments were conducted in adult male Wistar rats treated for 15 days with doxorubicin (DOXO, total dose 15 mg kg-1, i.p.) or saline (CONT). DOXO rats exhibited cardiotoxicity confirmed by histological examination without developing heart failure as estimated by echocardiography. However, HR variability increase reflected subtle microscopic changes of cardiac toxicity in DOXO rats. The results recommend time-frequency analysis of HRV for early detection of doxorubicin-induced cardiomyopathy. © 2015 Institute of Physics and Engineering in Medicine. - Some of the metrics are blocked by yourconsent settings
Publication Heart rate dynamics in doxorubicin-induced cardiomyopathy(2015) ;Lončar-Turukalo, T. (24478354200) ;Vasić, M. (56277862600) ;Tasić, T. (56394333000) ;Mijatović, G. (55513889700) ;Glumac, S. (33467624700) ;Bajić, D. (56186463400)Japunžić-Žigon, N. (56572866800)The clinical use of doxorubicin, an effective chemotherapeutic is hampered by the development of irreversible cardiotoxicity. Here we test time-frequency analysis of heart rate (HR) variability (HRV) for early detection of doxorubicin-induced cardiotoxicity. Experiments were conducted in adult male Wistar rats treated for 15 days with doxorubicin (DOXO, total dose 15 mg kg-1, i.p.) or saline (CONT). DOXO rats exhibited cardiotoxicity confirmed by histological examination without developing heart failure as estimated by echocardiography. However, HR variability increase reflected subtle microscopic changes of cardiac toxicity in DOXO rats. The results recommend time-frequency analysis of HRV for early detection of doxorubicin-induced cardiomyopathy. © 2015 Institute of Physics and Engineering in Medicine. 
